Lights and shadows of schizophrenia therapy research : Lessons from oral risperidone and olanzapine

Nicotra, Eraldo FLecca, DanieleCasu, GianlucaPalomba, MarioSil, AnneshaMarchese, Giorgio2020-02-212020-02-212020-05-01Nicotra, E F, Lecca, D, Casu, G, Palomba, M, Sil, A & Marchese, G 2020, 'Lights and shadows of schizophrenia therapy research : Lessons from oral risperidone and olanzapine', Journal of Psychopharmacology, vol. 34, no. 5, pp. 574-579. https://doi.org/10.1177/02698811199009800269-8811ORCID: /0000-0003-4270-2310/work/79061804https://hdl.handle.net/2164/137306367478645667engSDG 3 - Good Health and Well-beingAntipsychoticatypicalpatentsystematic analysisCLOZAPINEAUGMENTATIONCLINICAL-TRIALSANTIPSYCHOTIC-DRUGSDOUBLE-BLINDPHASE-22ND-GENERATIONR MedicinePsychiatry and Mental healthPharmacology (medical)PharmacologyRLights and shadows of schizophrenia therapy research : Lessons from oral risperidone and olanzapineJournal article10.1177/0269881119900980https://www.scopus.com/pages/publications/85078083060